{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:31:18Z","timestamp":1782927078822,"version":"3.54.5"},"reference-count":64,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: The COVID-19 pandemic has put enormous pressure on hospital resources, and has affected all aspects of patient care. As operative volumes decrease, cancer surgeries must be triaged and prioritized with careful thought and attention to ensure maximal benefit for the maximum number of patients. Peritoneal malignancies present a unique challenge, as surgical management can be resource intensive, but patients have limited non-surgical treatment options. This review summarizes current data on outcomes and resource utilization to help inform decision-making and case prioritization in times of constrained health care resources. Methods: A rapid literature review was performed, examining surgical and non-surgical outcomes data for peritoneal malignancies. Narrative data synthesis was cross-referenced with relevant societal guidelines. Peritoneal malignancy surgeons and medical oncologists reviewed recommendations to establish a national perspective on case triage and mitigating treatment strategies. Results and Conclusions: Triage of peritoneal malignancies during this time of restricted health care resource is nuanced and requires multidisciplinary discussion with consideration of individual patient factors. Prioritization should be given to patients where delay may compromise resectability of disease, and where alternative treatment options are lacking. Mitigating strategies such as systemic chemotherapy and\/or surgical deferral may be utilized with close surveillance for disease stability or progression, which may affect surgical urgency. Unique hospital capacity, and ability to manage the complex post-operative course for these patients must also be considered to ensure patient and system needs are aligned.<\/jats:p>","DOI":"10.3390\/curroncol28010006","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T04:55:31Z","timestamp":1611032131000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evidence-Based Strategies for the Treatment of Peritoneal Malignancies during Health Care Resource Restriction: The COVID-19 Pandemic"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-3010","authenticated-orcid":false,"given":"Farhana","family":"Shariff","sequence":"first","affiliation":[{"name":"University Health Network, Toronto, ON M5G 1L7, Canada"},{"name":"Division of Surgical Oncology, Department of Surgery, University of Toronto, Toronto, ON M5G 1L7, Canada"},{"name":"Mount Sinai Hospital, Toronto, ON M5G 1L7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Bischof","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, ON M5G 1L7, Canada"},{"name":"Division of Surgical Oncology, Department of Surgery, University of Toronto, Toronto, ON M5G 1L7, Canada"},{"name":"Mount Sinai Hospital, Toronto, ON M5G 1L7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Govindarajan","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, ON M5G 1L7, Canada"},{"name":"Division of Surgical Oncology, Department of Surgery, University of Toronto, Toronto, ON M5G 1L7, Canada"},{"name":"Mount Sinai Hospital, Toronto, ON M5G 1L7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Prince","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, ON M5G 1L7, Canada"},{"name":"Mount Sinai Hospital, Toronto, ON M5G 1L7, Canada"},{"name":"Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5G 1L7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-3623","authenticated-orcid":false,"given":"Ronald","family":"Burkes","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, ON M5G 1L7, Canada"},{"name":"Mount Sinai Hospital, Toronto, ON M5G 1L7, Canada"},{"name":"Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5G 1L7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Haase","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Alberta, Edmonton, AB T6G 2R3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mack","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walley","family":"Temple","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Hebbard","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Manitoba, Cancer Care Manitoba, Winnipeg, MN R3T 2N2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-7515","authenticated-orcid":false,"given":"Cindy","family":"Boulanger-Gobeil","sequence":"additional","affiliation":[{"name":"CHU de Qu\u00e9bec, D\u00e9partement de Chirurgie, Universit\u00e9 Laval, Quebec City, QC G1V 4G2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carman","family":"Giacomantonio","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dalhousie University, Halifax, NS B3H 4R2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9607-6987","authenticated-orcid":false,"given":"Alexandre","family":"Brind\u2019Amour","sequence":"additional","affiliation":[{"name":"Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Sid\u00e9ris","sequence":"additional","affiliation":[{"name":"Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dub\u00e9","sequence":"additional","affiliation":[{"name":"Maisonneuve-Rosemont Hospital, Montr\u00e9al, QC H1T 2M4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"MacNeill","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1M9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bouchard-Fortier","sequence":"additional","affiliation":[{"name":"Department of Surgery and Oncology, University of Calgary, Calgary, AB T2N 1N4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Younan","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC H2X 3E4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"McCart","sequence":"additional","affiliation":[{"name":"University Health Network, Toronto, ON M5G 1L7, Canada"},{"name":"Division of Surgical Oncology, Department of Surgery, University of Toronto, Toronto, ON M5G 1L7, Canada"},{"name":"Mount Sinai Hospital, Toronto, ON M5G 1L7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Spinelli, A., and Pellino, G. (2020). COVID-19 pandemic: Perspectives on an unfolding crisis. Br. J. Surg.","DOI":"10.1002\/bjs.11627"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Brindle, M., and Gawande, A. (2020). Managing COVID-19 in Surgical Systems. Ann. Surg.","DOI":"10.1097\/SLA.0000000000003923"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rosenbaum, L. (2020). Facing Covid-19 in Italy\u2014Ethics, Logistics, and Therapeutics on the Epidemic\u2019s Front Line. N. Engl. J. Med.","DOI":"10.1056\/NEJMp2005492"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ueda, M., Martins, R., Hendrie, P.C., McDonnell, T., Crews, J.R., Wong, T.L., McCreery, B., Jagels, B., Crane, A., and Byrd, D.R. (2020). Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J. Natl. Compr. Cancer Netw., 1\u20134.","DOI":"10.6004\/jnccn.2020.7560"},{"key":"ref_5","unstructured":"Cancer Care Ontario (2020). COVID-19 Supplemental Clinical Guidance for Patients with Cancer. Dis. Manag. Resour., in press."},{"key":"ref_6","unstructured":"Society of Surgical Oncology Peritoneal Surface Malignancies Disease Site Work Group (2020). Resource for Management Options of Peritoneal Surface Malignancies During COVID-19. Dis. Site Specif. Manag. Resour., in press."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1503\/cjs.005620","article-title":"Canadian Society of Surgical Oncology. Guidance for management of cancer surgery during COVID-19 pandemic","volume":"63","author":"Finley","year":"2020","journal-title":"Can. J. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Truog, R.D., Mitchell, C., and Daley, G.Q. (2020). The Toughest Triage\u2014Allocating Ventilators in a Pandemic. N. Engl. J. Med.","DOI":"10.1056\/NEJMp2005689"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bartlett, D.L., Howe, J.R., Chang, G., Crago, A., Hogg, M., Karakousis, G., Levine, E., Maker, A., Mamounas, E., and McGuire, K. (2020). Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann. Surg. Oncol.","DOI":"10.1245\/s10434-020-08461-2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/path.4942","article-title":"The peritoneum: Healing, immunity, and diseases","volume":"243","author":"Capobianco","year":"2017","journal-title":"J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lei, S., Jiang, F., Su, W., Chen, C., Chen, J., Mei, W., Zhan, L.Y., Jia, Y., Zhang, L., and Liu, D. (2020). Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine, 100331.","DOI":"10.1016\/j.eclinm.2020.100331"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10397-020-01070-7","article-title":"Laparoscopy in the coronavirus disease 2019 (COVID-19) era","volume":"17","author":"Angioni","year":"2020","journal-title":"Gynecol. Surg."},{"key":"ref_14","unstructured":"National Comprehensive Cancer Network (2020, June 01). Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community. Available online: https:\/\/www.nccn.org\/covid-19\/."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Tricco, A.C., Antony, J., Zarin, W., Strifler, L., Ghassemi, M., Ivory, J., Perrier, L., Hutton, B., Moher, D., and Straus, S.E. (2015). A scoping review of rapid review methods. BMC Med., 13.","DOI":"10.1186\/s12916-015-0465-6"},{"key":"ref_16","first-page":"2161952","article-title":"Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis","volume":"2016","author":"Kehagias","year":"2016","journal-title":"Case Rep. Oncol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archsurg.138.6.585","article-title":"Surgical treatment of appendiceal mucocele","volume":"138","author":"Stocchi","year":"2003","journal-title":"Arch. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1634\/theoncologist.2017-0081erratum","article-title":"Appendiceal Mucinous Neoplasms: Diagnosis and Management","volume":"23","author":"Shaib","year":"2018","journal-title":"Oncologist"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejso.2006.03.016","article-title":"The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms","volume":"32","author":"Sugarbaker","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1477-7819-9-169","article-title":"Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)","volume":"9","author":"Cooksley","year":"2011","journal-title":"World J. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1245\/s10434-013-3283-0","article-title":"Mucinous tumor of the appendix with limited peritoneal spread: Is there a role for expectant observation?","volume":"21","author":"Zih","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jamcollsurg.2010.06.011","article-title":"Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: A study of timing and the impact of malignant dedifferentiation","volume":"211","author":"Chua","year":"2010","journal-title":"J. Am. Coll. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","article-title":"Long-term survival following treatment of pseudomyxoma peritonei: An analysis of surgical therapy","volume":"241","author":"Miner","year":"2005","journal-title":"Ann. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1245\/s10434-009-0341-8","article-title":"Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution","volume":"16","author":"Chua","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PPO.0b013e3181a9c781","article-title":"Epithelial appendiceal neoplasms","volume":"15","author":"Sugarbaker","year":"2009","journal-title":"Cancer J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1245\/s10434-008-0073-1","article-title":"Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: Preliminary results of a survival analysis","volume":"15","author":"Marcotte","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1245\/s10434-007-9462-0","article-title":"Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms","volume":"14","author":"Yan","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1245\/s10434-015-5019-9","article-title":"Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei?","volume":"23","author":"Delhorme","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: Optimal management review","volume":"25","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1245\/s10434-016-5712-3","article-title":"The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review","volume":"24","author":"Waite","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chicago Consensus Working Group (2020). The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. Cancer, 126, 2534\u20132540.","DOI":"10.1002\/cncr.32874"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","article-title":"Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer","volume":"23","author":"Faron","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ejso.2018.10.086","article-title":"A UNICANCER phase III trial of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Carcinomatosis. PRODIGE 7","volume":"45","author":"Quenet","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(03)12461-0","article-title":"Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: A multicentre randomised trial","volume":"361","author":"Maughan","year":"2003","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2018.36.15_suppl.3531","article-title":"Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-NTC01226394)","volume":"36","author":"Goere","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_43","first-page":"135","article-title":"Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix","volume":"52","author":"Sideris","year":"2009","journal-title":"Can. J. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2017.12.027","article-title":"A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors","volume":"226","author":"Levine","year":"2018","journal-title":"J. Am. Coll. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/annonc\/mdr279","article-title":"Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix","volume":"23","author":"Lieu","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cncr.24715","article-title":"Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: A single-institution experience","volume":"116","author":"Shapiro","year":"2010","journal-title":"Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1245\/s10434-018-6337-5","article-title":"Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma","volume":"25","author":"Alexander","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: A systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: Outcomes of an expanded access program","volume":"7","author":"Janne","year":"2005","journal-title":"Clin. Lung Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Chicago Consensus Working Group (2020). The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer, 126, 2547\u20132552.","DOI":"10.1002\/cncr.32870"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12032-018-1125-4","article-title":"The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking","volume":"35","author":"Naffouje","year":"2018","journal-title":"Med. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1470-2045(09)70069-5","article-title":"Nosocomial infections in patients with cancer","volume":"10","author":"Kamboj","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_54","first-page":"CD008983","article-title":"Influenza vaccines in immunosuppressed adults with cancer","volume":"2","author":"Bitterman","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Burki, T.K. (2020). Cancer guidelines during the COVID-19 pandemic. Lancet Oncol.","DOI":"10.1016\/S1470-2045(20)30217-5"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"You, B., Ravaud, A., Canivet, A., Ganem, G., Giraud, P., Guimbaud, R., Kaluzinski, L., Krakowski, I., Mayeur, D., and Grellety, T. (2020). The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol.","DOI":"10.1016\/S1470-2045(20)30204-7"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejso.2020.01.017","article-title":"Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center","volume":"46","author":"Li","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4240\/wjgs.v10.i5.49","article-title":"Approach to pseudomyxoma peritonei","volume":"10","author":"Rizvi","year":"2018","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_59","first-page":"307317","article-title":"Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?","volume":"2014","year":"2014","journal-title":"J. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jss.2019.10.042","article-title":"Cytoreductive Surgery and HIPEC in an Enhanced Recovery After Surgery Program: A Feasibility Study","volume":"247","author":"Lu","year":"2020","journal-title":"J. Surg. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Shander, A., Goobie, S.M., Warner, M.A., Aapro, M., Bisbe, E., Perez-Calatayud, A.A., Callum, J., Cushing, M.M., Dyer, W.B., and Erhard, J. (2020). The Essential Role of Patient Blood Management in a Pandemic: A Call for Action. Anesth. Analg.","DOI":"10.1213\/ANE.0000000000004844"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pagano, M.B., Hess, J.R., Tsang, H.C., Staley, E., Gernsheimer, T., Sen, N., Clark, C., Nester, T., Bailey, C., and Alcorn, K. (2020). Prepare to adapt: Blood supply and transfusion support during the first 2 weeks of the 2019 Novel Coronavirus (COVID-19) pandemic affecting Washington State. Transfusion.","DOI":"10.1111\/trf.15789"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s11605-017-3444-8","article-title":"Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Review of 936 Cases","volume":"21","author":"Saxena","year":"2017","journal-title":"J. Gastrointest. Surg."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1245\/s10434-018-6630-3","article-title":"Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC","volume":"25","author":"Nizri","year":"2018","journal-title":"Ann. Surg. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:40:19Z","timestamp":1760179219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["curroncol28010006"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28010006","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}